AnGes files patent for crispr-based method for modifying mutant lRRK2 gene in cells
Discover how AnGes Inc. is revolutionizing Parkinson's disease treatment with RNA molecules and CRISPR technology. Learn about their patent for precise genetic modifications.
Discover how AnGes Inc. is revolutionizing Parkinson's disease treatment with RNA molecules and CRISPR technology. Learn about their patent for precise genetic modifications.
What's Your Reaction?
